Bortezomib with lenalidomide and dexamethasone versus...

The Lancet 2017 / 02 Vol. 389; Iss. 10068

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

Durie, Brian G M, Hoering, Antje, Abidi, Muneer H, Rajkumar, S Vincent, Epstein, Joshua, Kahanic, Stephen P, Thakuri, Mohan, Reu, Frederic, Reynolds, Christopher M, Sexton, Rachael, Orlowski, Robert Z
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
389
Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(16)31594-X
Date:
February, 2017
File:
PDF, 465 KB
english, 2017
Conversion to is in progress
Conversion to is failed